Tag Archives: Cortene

Treatment Research: Cortene’s InTime trial of CT38 results in sustained symptom improvement in ME/CFS

Posted on 09/07/2021 by wames

Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Results in Sustained Symptom Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by Gerard Pereira, Hunter Gillies, Sanjay Chanda, Michael Corbett, Suzanne D. Vernon, Tina Milani and Lucinda Bateman in Front. Syst. Neurosci., 01 Sep … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Treatment Research: Cortene’s InTime trial of CT38 results in sustained symptom improvement in ME/CFS

Cortene – a new drug trial & disease hypothesis for ME/CFS

Posted on 03/26/2018 by wames

Cortene In his blog, Health Rising, Cort Johnson introduces a new drug trial and hypothesis for ME/CFS. With the help of Dr Lucinda Bateman and Dr Suzanne Vernon a small drug company, Cortene, will be conducting a small proof-of-concept trial of a new … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Cortene – a new drug trial & disease hypothesis for ME/CFS